Publication:

Aβ Imaging: Feasible, Pertinent, and Vital to Progress in Alzheimer’s Disease

Thumbnail Image

Open/View Files

Primary 3261395.pdf (425.93 KB)

Date

2012

Authors

Published Version

10.1007/s00259-011-2045-0

Journal Title

Journal ISSN

Volume Title

Publisher

Springer-Verlag
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Villemagne, Victor L., William E. Klunk, Chester A. Mathis, Christopher C. Rowe, David J. Brooks, Bradley T. Hyman, Milos D. Ikonomovic, et al. 2012. Aβ Imaging: Feasible, pertinent, and vital to progress in Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging 39(2): 209-219.

Abstract

Description

Other Available Sources

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261395/pdf/

Research Data

Keywords

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

URI

http://nrs.harvard.edu/urn-3:HUL.InstRepos:9361509

Collections

HMS Scholarly Articles

Endorsement

Review

Supplemented By

Related Stories